Insmed Incorporated (INSM) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Tiffany and I will be your conference operator today. At this time, I would like to welcome everyone to the InSmith second quarter 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, Simply press star, then the number one on your telephone keypad. I would now like to turn the call over to Brian Dunn, Head of Investor Relations. Brian, please go ahead. Thank you, Tiffany. Good day, everyone, and welcome to today's conference call in which we will discuss Innsmed's second quarter 2025 financial results and provide an update on our business. Before we start, please note that today's call will include forward-looking statements based on our current expectations. These statements represent our judgment as of today and inherently involve risks and uncertainties that may cause actual results to differ materially from the projections discussed. Please refer to our filings with the Securities and Exchange Commission for more information. The information we will discuss on today's call is meant for the benefit of the investment community. It is not intended for promotional purposes and it is not sufficient for prescribing decisions. Today's call will feature prepared comments by Will Lewis, Chair and Chief Executive Officer, Roger Adset, Chief Operating Officer, and Sarah Bonstein, Chief Financial Officer. After their comments, they will be joined by Martina Flammer, Chief Medical Officer, for the Q&A session. I will now turn the call over to Will. Thank you, Brian, and welcome, everyone. As I reflect on the first half of 2025, I am enormously pleased with wh...